Journals / Haseki Tıp Bülteni / 2022 / Cilt: 60 - Sayı: 2

Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism

Pages
145–151
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

ATRIA and CHA2DS2-VASc scores were higher in the PE group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Pulmonary embolism (PE) is a condition caused by thrombosis and is a common cause of death.
📊
Key Findings & Data:Although there are studies of PE with CHA2DS2-VASc (C: congestive heart failure or left ventricular systolic dysfunction, H: hypertension, A: age of ≥75 years, D: diabetes mellitus, S: previous stroke, V: vascular disease, A: age between 65 and 74 years, Sc: female gender) and PE severity index (PESI) scores, there is no data on Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) score in PE or comparison of CHA2DS2- VASc and ATRIA scores in PE.
💡
Conclusion & Impact:ATRIA and CHA2DS2-VASc scores were higher in the PE group (p
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Pulmonary embolism (PE) is a condition caused by thrombosis and is a common cause of death. Although there are studies of PE with CHA2DS2-VASc (C: congestive heart failure or left ventricular systolic dysfunction, H: hypertension, A: age of ≥75 years, D: diabetes mellitus, S: previous stroke, V: vascular disease, A: age between 65 and 74 years, Sc: female gender) and PE severity index (PESI) scores, there is no data on Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) score in PE or comparison of CHA2DS2- VASc and ATRIA scores in PE. We investigated whether ATRIA and CHA2DS2-VASc scores can predict PE and mortality in cases of PE. Methods: One hundred ninety-eight patients with PE and two hundred eighty controls between July 2017 and July 2021 were included in this retrospective study. Patients’ data was provided from the hospital’s digital system. Patients’ PESI, ATRIA, and CHA2DS2-VASc scores were calculated, and in-hospital mortality was determined as the primary end-point. Results: The mean age of the patients was 63.9±13.1 years. The frequency of male patients in the PE group was higher (p=0.04), but this difference was invalid in patients with PE who developed primary end-point (p=0.177). ATRIA and CHA2DS2-VASc scores were higher in the PE group (p

🔖

Cite This Article

Dogdus, M., Dindas, F., Abacioglu, O. O., Koyunsever, N. Y., Karadeniz, M., Yildirim, A., Abacioglu, S. (2022). Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism. Haseki Tıp Bülteni, Cilt: 60 - Sayı: 2, 145–151. https://ajindex.com/articles/534942

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bĕlohlávek J, Dytrych V, Linhart. A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol 2013;18:129-38
  2. Marconi L, Carrozzi L, Aquilini F, Celi A, Pistelli F, Palla A. Five-year follow-up of pulmonary embolism under anticoaugulation: The PISA-PEET (Pulmonary Embolism Extension Therapy) study. Medicine (Baltimore) 2016;95:e4364
  3. Altınsoy B, Erboy F, Tanrıverdi H, et al. Syncope as a presentation of acute pulmonary embolism. Ther Clin Risk Manag 2016;12:1023-8
  4. Ishaaya E, Tapson VF. Advances in the diagnosis of acute pulmonary embolism. F1000Res 2020;9:F1000 Faculty Rev-44
  5. Morrone D, Morrone V. Acute Pulmonary Embolism: Focus on the Clinical Picture. Korean Circ J 2018;48:365-81
  6. Chung HC, Lee CC, Lin YH. Clinical Manifestations and Prognostic Factors of Pulmonary Embolism in Adult Patients Visiting the Emergency Department: A Single Institute Experience. J Acute Med 2019;9:16-23
  7. Akyol PY, Karakaya Z, Topal FE, Payza U, Kaykısız EK. Simplified Pulmonary Embolism Severity Index in Predicting Mortality in Emergency Department. Konuralp Tıp Dergisi 2019;11:314-9
  8. Barnes GD, Muzikansky A, Cameron S, et al. Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response Teams. JAMA Netw Open 2020;3:e2010779
  9. Penaloza A, Melot C, Motte S. Comparison of the Wells score with the simplified revised Geneva score for assessing pretest probability of pulmonary embolism. Thromb Res 2011;127:81-4
  10. Shen JH, Chen HL, Chen JR, Xing JL, Gu P, Zhu BF. Comparison of the Wells score with the revised Geneva score for assessing suspected pulmonary embolism: a systematic review and meta-analysis. J Thromb Thrombolysis 2016;41:482-92
  11. Piovella F, Iosub DI. Acute pulmonary embolism: risk assessment, risk stratification and treatment options. Clin Respir J 2016;10:545-54
  12. Zhou XY, Ben SQ, Chen HL, Ni SS. The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis. Respir Res 2012;13:111
  13. Essien EO, Rali P, Mathai SC. Pulmonary Embolism. Med Clin North Am 2019;103:549-64
  14. Singer DE, Chang Y, Borowsky LH, et al. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc 2013;2:e000250
  15. Kim TH, Yang PS, Uhm YS, et al. CHA2DS